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 A rare case of bone cryptococcosis solely involving the 
skull is presented. A 63-year-old man had received an 
antituberculous treatment for pulmonary tuberculosis. His 
initial symptom was a headache that was followed by a de-
velopment of slow growing elastic soft mass in the right 
parietal region. CT scan showed a well-circumscribed smooth 
margined mass in the parietal bone associated with osteo 
lytic changes. On aspiration biopsy an abscess containing 
abundant Cryptococcus neoformans was observed. He was 
treated with drainage and irrigation of abscess and 
craniectomy of the right parietal bone. He also received 
200mg of oral fluconazole. About half of the patients with 
skeletal cryptococcosis have underlying diseases that cause 
abnormalities of cellular immunity (e.g., lymphoma, leuke-
mia, sarcoidosis, TB etc), or are receiving therapies that af-
fect cell mediated immunity (e.g., a long-term steroid ther-
apy). It is assumed that his cell-mediated immunity was 
decreased because of his low lymphocyte value and his un-
derlying disease. Clinical and radiological manifestations 
of bone cryptococcosis are non-specific. It should be in-
cluded in the differential diagnosis, especially in the pa-
tients with bone abscess who has underlying diseases. 
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Introduction
 Bone cryptococcosis occurs in only 5 to 10% of the 
patients with disseminated cryptococcosis. Moreover 
the disease localized to bone is very rare. A case of 
cryptococcal osteomyelitis of the skull that developed 
during the treatment of pulmonary tuberculosis is pre-
sented with review of the literature.
Case Report
 A 63-year-old man had received an antituberculous 
treatment for 6-months using INH, REF, EB and PZA, 
since September 2001. He began to complain of a 
headache at the end of November 2001, and it became 
a right-sided migraine-like headache on December 2001. 
No abnormal neurological findings were observed. CT 
scan of the head obtained on December 17th was re-
ported normal (Fig 1). Retrospectively it showed sub-
tle abnormality in the right parietal region. He was 
followed-up under the treatment with anodyne but his 
symptom did not improve, and he developed an elastic 
soft mass gradually growing in the painful region. 
Follow up CT scan showed a mass formation in both the 
inner and outer tables of cranial bone with osteolytic 
changes (Fig. 2). The mass was well circumscribed and 
its margin was smooth. There was slight compression 
of the right parietal lobe of the brain, but no invasion 
into the brain parenchyma. Intracranial component of 
the mass showed an appearance of epidural lesion. 
The attenuation of the mass was slightly lower than 
that of the soft tissue. Bone metastasis was first sus-
pected because of its frequency and the age of the pa-
tient. In addition, an abscess (e.g., cold abscess) was 
also considered as a differential diagnosis.
Shintaro Yoshida et al : Skull Cryptococcal Osteomyelitis
Table 1.
           Sep.2001 Jan.2002 
ESR (1h) 78 100 mm 
CRP 14.9 6.2 mg/I 
WBC 9100 7100 /c1 
       (Nt 87 Ly 6 Mo 6 Ba 1) 
RBC 407 460 x104/,u I 
       (Hb 10.3 Ht 31.2) (Hb 12.9 Ht 39.1) 
TP 5.9 8.4 g/dl 
Alb 2.3 4.0 g/dl 
AST 52 25 IU/I 
ALT 49 15 IU/I 
LDH 202 165 U/1 
ALP 423 418 IU/1 
BUN 14 15 mg/dl 
Cre 0.4 0.8 mg/dl 
Tuberculin test 0 X 0/10 X 20 (mm) CEA 5.2 ng/ml
Figure 2. a : Non-enhanced transverse CT scan of the head 
showing a mass formation in both the inner and outer tables 
of the cranial bone. b : Different window setting of the same 
slice better showing lytic changes of the parietal bone.
 Main laboratory data, on admission of September 
2001 and on January 2002 when the second head CT 
was taken, are shown in Table 1. The erythrocyte 
sedimentation rate (ESR) and C-reactive protein (CRP) 
were high, but a white blood cell count was not re-
markably high. CRP improved in four months. Anemia 
and hypoproteinemia observed on admission also im-
proved. Since liver dysfunction was not observed, che-
motherapy for pulmonary tuberculosis using drugs in-
cluding PZA was continued as initially planned. Renal 
function was normal. A tuberculin skin test on admis-
sion was positive, but its erythema diameter was less 
than 30mm, and there was no induration. In differen-
tial white blood count, lymphocyte value was low, 
only 6% (absolute value: 546/ 1). As bone metastasis 
was suspected, tumor marker carcinoembryonic anti-
gen (CEA) was examined but it was not high.
Main laboratory data which were obtained on September 2001 when he was 
hospitalized and on January 2002 when he received the second head CT.
 Cytological diagnosis on the initial aspiration biopsy 
indicated the mass of class I, and there were no malig-
nant cells in the sputum. The mass gradually enlarged 
afterwards, and a fluid like abscess and abundant Cryp-
tococcus neoformans were observed on re-aspiration bi-
opsy (Fig.3). 
 Chest radiographs and chest CT obtained on admis-
sion and at the time of biopsy are presented in Fig.4. 
Lung opacity with multiple cavity formations of the 
bilateral upper lung fields observed on admission was 
decreased by anti-tuberculous therapy. The middle 
and lower lung fields were clear. No new lesions or 
opacities indicating Cryptococcal pneumonia or lung 
tumor were observed. Bone scintigram was not per-
formed. 
 Based on above findings, the patient was diagnosed 
as having isolated cranial bone cryptococcosis with 
abscess formation. He was sent to the department of 
neurosurgery of another hospital, and received
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drainage and irrigation of abscess and craniectomy of 
the right parietal bone on March 8th 2002. He was 
treated with 200mg of oral fluconazole afterwards, but 
cryptococcal antigen in serum, as of July 18th 2002 
was positive (titer 1:128). When the infection disap-
pears completely, he is to receive cranioplastic sur-
gery.
Discussion
Figure 3. a : Fluid acquired by aspiration biopsy of the mass. 
b : Abundant Cryptoccocus neoformans with the neutrophils 
and epithelioid cells. c : Indian ink smear revealing encapsu-
lated yeast-like fungi whose capsule shell is very thick and 
transparent. d : Many smooth, creamy-white colonies on 
Sabouraud's media.
Figure 4. Chest radiographs (a, b) and plain chest CTs (c, 
d).On admission, lung opacities with multiple cavity forma-
tions of bilateral upper lung fields were observed (a, c). 
They improved after anti-tuberculous therapy for about 5 
months (b, d).
 Pathogen of cryptococcosis is yeast like fungus, 
Cryptococcus neoformans, which is a ubiquitous fungus 
widely distributed and found especially in the bird drop-
pings and in the soil. It dries and floats in the air. 
Human is infected by inhalation of its airborne parti-
cles. Therefore, it is considered that one of the important 
precautions is to remove droppings of birds such as 
pigeon. There is no evidence of direct infection (e.g, 
human to human, and animal to human). It is believed 
that any organ can be invaded by hematogenous spread 
from primary pulmonary infection. Bone cryptococcosis 
occurs in only 5 to 10% of the patients with dissemi-
nated disease, and the disease localized in bones with-
out involvement of other organ is very rare."' 
 According to Wood et al. (1996), about a half of the 
patients with skeletal cryptococcosis have underlying 
diseases that cause abnormalities of cellular immunity 
(e.g., lymphoma, leukemia, sarcoidosis, diabetes melli-
tus, cancer, SLE and TB), or have had treatment that 
affect cell mediated immunity (e.g., a long-term steroid 
therapy).' 2, ;1, 51 In addition, even seemingly immunocompetent 
patients frequently have laboratory abnormalities of 
cell-mediated immunity.2' 1' In our case, lymphocyte 
value was low and the result of tuberculin test was 
relatively weak, although he had advanced pulmonary 
tuberculosis of 10 Gaffky scale. Therefore his cell-
mediated immunity must have been decreased. 
 The disease may involve any bone, but the vertebrae, 
pelvis and ribs are most frequently involved. The dis-
ease may occur in either a single site or multiple sites 
1-10). Symptoms of skeletal cryptococcosis include soft 
tissue swelling and pain. Fever is not frequently ob-
served (18%). ESR rises in variable ranges and white 
blood cell count is often normal. The cryptococcal an-
tigen in serum has high sensitivity and specificity, but 
serum cryptococcal antibodies are present in only 30 
to 40% of the patients. Therefore, the value of the an-
tibody examination is limited.' 
 Radiologically, the disease is manifested as an 
osteolytic lesion with overlying soft tissue mass.'-' The 
lesion is usually not accompanied with sclerotic change 
or periosteal reaction around the lesion: a non-specific
finding. As differential diagnosis, infectious diseases, 
neoplasms and other benign diseases should be consid-
ered." Infectious diseases include other mycotic and 
bacterial infectious diseases such as Staphylococcus 
aureus, brucella, actinomyces, mycobacterium tuberculosis 
and atypical mycobacteria. Neoplasms include primary 
osteogenic sarcoma, myeloma, and bone metastasis. In 
addition, parietal foramina, dermoid cyst, hemangioma 
and meningocele should also be considered as differen-
tial diagnosis. Since clinical or radiological findings of 
skeletal cryptococcosis are not specific, its correct di-
agnosis is often delayed or not made ante-mortem.2' 
 The treatment for skeletal cryptococcosis is medica-
tion using amphotericin B with or without surgical in-
tervention.1-10' The dosage and duration of medication 
has not been clearly established yet. The oral azoles 
have been used for cryptococcosis, especially for cryp-
tococcal meningitis in AIDS patients. There are some 
reports indicating the effectiveness of oral azoles for 
cryptococcal diseases not involving the central nerv-
ous system in patients without AIDS."" Amphotericin 
B causes adverse effects such as nephrotoxicity. It 
takes 4 to 5 hours to intravenously infuse, and long-
term administration is required. Therefore, in our case, 
fluconazole was selected from the beginning. 
 In summary we reported a case of bone cryptococcosis, 
one of the rare manifestations of cryptococcosis, ac-
companied by pulmonary tuberculosis. Our patient had 
abnormalities of cell mediated immunity that was in
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agreement with those reported in the literature. Because 
bone cryptococcosis is clinically and radiologically non-
specific, it is important to include it in a differential 
diagnosis, especially in patients with bone abscess who 
has underlying diseases.
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